Pulmonary hypertension in systemic sclerosis
Authors:
- Christopher P DentonCDChristopher P Denton
- Carol M BlackCBCarol M Black
- 1 May 2003
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 29 (2) , 335-349
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Analysis of transforming growth factor β1 gene polymorphisms in patients with systemic sclerosisAnnals of the Rheumatic Diseases, 2002
- Functional analysis of bone morphogenetic protein type II receptor mutations underlying primary pulmonary hypertensionHuman Molecular Genetics, 2002
- The heart and pulmonary vasculature in scleroderma: clinical features and pathobiologyCurrent Opinion in Rheumatology, 2001
- Clinical and Molecular Genetic Features of Pulmonary Hypertension in Patients with Hereditary Hemorrhagic TelangiectasiaNew England Journal of Medicine, 2001
- Association of fibrillin 1 single-nucleotide polymorphism haplotypes with systemic sclerosis in Choctaw and Japanese populationsArthritis & Rheumatism, 2001
- Mutations in the TGF-beta type 1 receptor, ALK1, in combined primary pulmonary hypertension and hereditary haemorrhagic telangiectasia, implies pathway specificityThe Journal of Heart and Lung Transplantation, 2001
- Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-β familyJournal of Medical Genetics, 2000
- Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertensionNature Genetics, 2000
- Pulmonary vascular changes in sclerodermaThe American Journal of Medicine, 1978
- The heart in sclerodermaThe American Journal of Cardiology, 1966